Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.

Literature DB >> 23227279

Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.

Jerry D Estep¹, Arvind Bhimaraj, A M Cordero-Reyes, Brian Bruckner, Matthias Loebe, Guillermo Torre-Amione.

Abstract

Cardiac amyloidosis is one of the most common of the infiltrative cardiomyopathies and is associated with a poor prognosis. The extent of cardiac involvement with amyloid deposition is an important determinant of treatment options and is the major determinant of outcome in patients with amyloidosis. Several small case series with sequential orthotopic heart transplantation and autologous stem cell transplant have demonstrated an improvement in post-transplant outcome and have revived enthusiasm about heart transplantation for patients with end-stage heart failure due to AL amyloidosis. The purpose of this review is to summarize the evaluation and management of cardiac amyloidosis and to provide our single-center experience with end-stage heart failure due to AL amyloidosis treated with heart transplantation followed by an autologous stem cell transplant.

Entities: Disease Species

Keywords: AL amyloidosis; Cardiac amyloidosis; amyloid protein; autologous hematopoietic stem cell transplant; end-stage cardiac amyloidosis

Mesh：

Year: 2012 PMID： 23227279 PMCID： PMC3487570 DOI： 10.14797/mdcj-8-3-8

Source DB: PubMed Journal: Methodist Debakey Cardiovasc J ISSN： 1947-6108

29 in total

Review 1. Amyloidosis.

Authors: M A Gertz; M Q Lacy; A Dispenzieri
Journal: Hematol Oncol Clin North Am Date: 1999-12 Impact factor: 3.722

2. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Authors: Martin Ugander; Abiola J Oki; Li-Yueh Hsu; Peter Kellman; Andreas Greiser; Anthony H Aletras; Christopher T Sibley; Marcus Y Chen; W Patricia Bandettini; Andrew E Arai
Journal: Eur Heart J Date: 2012-01-24 Impact factor: 29.983

3. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.

Authors: S W Dubrey; K Cha; J Anderson; B Chamarthi; J Reisinger; M Skinner; R H Falk
Journal: QJM Date: 1998-02

4. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement.

Authors: P A Pellikka; D R Holmes; W D Edwards; R A Nishimura; A J Tajik; R A Kyle
Journal: Arch Intern Med Date: 1988-03

5. Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis.

Authors: F Pelosi; J Capehart; W C Roberts
Journal: Am J Cardiol Date: 1997-02-15 Impact factor: 2.778

6. Cardiac replacement with a total artificial heart as a bridge to transplantation.

Authors: Jack G Copeland; Richard G Smith; Francisco A Arabia; Paul E Nolan; Gulshan K Sethi; Pei H Tsau; Douglas McClellan; Marvin J Slepian
Journal: N Engl J Med Date: 2004-08-26 Impact factor: 91.245

7. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins.

Authors: Angela Dispenzieri; Robert A Kyle; Morie A Gertz; Terry M Therneau; Wayne L Miller; Krishnaswamy Chandrasekaran; Joseph P McConnell; Mary F Burritt; Allan S Jaffe
Journal: Lancet Date: 2003-05-24 Impact factor: 79.321

8. Cardiac transplantation for amyloid heart disease: the United Kingdom experience.

Authors: Simon W Dubrey; Margaret M Burke; Philip N Hawkins; Nicholas R Banner
Journal: J Heart Lung Transplant Date: 2004-10 Impact factor: 10.247

9. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

Authors: Angela Dispenzieri; Morie A Gertz; Robert A Kyle; Martha Q Lacy; Mary F Burritt; Terry M Therneau; Philip R Greipp; Thomas E Witzig; John A Lust; S Vincent Rajkumar; Rafael Fonseca; Steven R Zeldenrust; Christopher G A McGregor; Allan S Jaffe
Journal: J Clin Oncol Date: 2004-09-15 Impact factor: 44.544

10. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.

Authors: A L Klein; L K Hatle; C P Taliercio; J K Oh; R A Kyle; M A Gertz; K R Bailey; J B Seward; A J Tajik
Journal: Circulation Date: 1991-03 Impact factor: 29.690

6 in total

Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.

Review 1. Amyloidosis.

2. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

3. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.

4. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement.

5. Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis.

6. Cardiac replacement with a total artificial heart as a bridge to transplantation.

7. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins.

8. Cardiac transplantation for amyloid heart disease: the United Kingdom experience.

9. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

10. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.

1. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.

Review 2. Heart transplantation in cardiac amyloidosis.

3. Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure.

4. Cardiac amyloidosis: a challenging diagnosis.

Review 5. Advances in the Treatment of Cardiac Amyloidosis.

6. Cardiac amyloidosis: The great masquerader.